UTHR (United Therapeutics Corp) may reap gains as insiders became active recently

Daniel Torres

United Therapeutics Corp’s filing revealed that its FOUNDER, CHAIRPERSON, AND CHIE ROTHBLATT MARTINE A acquired Company’s shares for reported $1.88 million on Nov 24 ’25. In the deal valued at $470.78 per share,4,000 shares were bought.

Then, ROTHBLATT MARTINE A sold 4,000 shares, generating $1,913,524 in total proceeds. Upon selling the shares at $478.38, the Chairperson & CEO now owns 130 shares.

Before that, ROTHBLATT MARTINE A sold 4,000 shares. United Therapeutics Corp shares valued at $1,898,558 were divested by the Chairperson & CEO at a price of $474.64 per share. As a result of the transaction, ROTHBLATT MARTINE A now holds 130 shares, worth roughly $62036.0.

Wells Fargo initiated its United Therapeutics Corp [UTHR] rating to an Underweight in a research note published on October 20, 2025; the price target was $414. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who began to cover the stock in late September with a ‘”an Outperform”‘ rating. Cantor Fitzgerald began covering UTHR with “an Overweight” recommendation on June 02, 2025. Wells Fargo revised its rating on April 25, 2025. It rated UTHR as “an Equal weight” which previously was an “an Overweight”.

Price Performance Review of UTHR

On Monday, United Therapeutics Corp [NASDAQ:UTHR] saw its stock jump 0.50% to $477.2. Over the last five days, the stock has gained 1.12%. United Therapeutics Corp shares have risen nearly 30.98% since the year began. Nevertheless, the stocks have risen 35.25% over the past one year. While a 52-week high of $485.32 was reached on 11/18/25, a 52-week low of $266.98 was recorded on 04/09/25.

Levels Of Support And Resistance For UTHR Stock

The 24-hour chart illustrates a support level at 468.47, which if violated will result in even more drops to 459.74. On the upside, there is a resistance level at 484.18. A further resistance level may holdings at 491.16.

How much short interest is there in United Therapeutics Corp?

A steep rise in short interest was recorded in United Therapeutics Corp stocks on 2025-10-31, dropping by -0.51 million shares to a total of 1.68 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 2.19 million shares. There was a decline of -30.37%, which implies that there is a negative sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.